303 related articles for article (PubMed ID: 11470832)
1. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
2. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling.
Iyer AK; Tran KT; Griffith L; Wells A
J Cell Physiol; 2008 Feb; 214(2):504-12. PubMed ID: 17708541
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation.
Liu A; Garg P; Yang S; Gong P; Pallero MA; Annis DS; Liu Y; Passaniti A; Mann D; Mosher DF; Murphy-Ullrich JE; Goldblum SE
J Biol Chem; 2009 Mar; 284(10):6389-402. PubMed ID: 19129184
[TBL] [Abstract][Full Text] [Related]
4. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
5. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
Liu Y; Li R; Ladisch S
J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
[TBL] [Abstract][Full Text] [Related]
6. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.
Shiraha H; Glading A; Gupta K; Wells A
J Cell Biol; 1999 Jul; 146(1):243-54. PubMed ID: 10402474
[TBL] [Abstract][Full Text] [Related]
7. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
[TBL] [Abstract][Full Text] [Related]
9. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Xu KP; Ding Y; Ling J; Dong Z; Yu FS
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.
Jones PL; Crack J; Rabinovitch M
J Cell Biol; 1997 Oct; 139(1):279-93. PubMed ID: 9314546
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
Decker SJ
J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-like repeats of tenascin-C-induced constriction of cerebral arteries via activation of epidermal growth factor receptors in rats.
Fujimoto M; Shiba M; Kawakita F; Liu L; Nakasaki A; Shimojo N; Imanaka-Yoshida K; Yoshida T; Suzuki H
Brain Res; 2016 Jul; 1642():436-444. PubMed ID: 27086972
[TBL] [Abstract][Full Text] [Related]
13. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix signaling through growth factor receptors during wound healing.
Tran KT; Griffith L; Wells A
Wound Repair Regen; 2004; 12(3):262-8. PubMed ID: 15225204
[TBL] [Abstract][Full Text] [Related]
15. Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation.
Nandagopal K; Popp DM; Niyogi SK
J Cell Biochem; 2001 Aug 1-9; 83(2):326-41. PubMed ID: 11573249
[TBL] [Abstract][Full Text] [Related]
16. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
17. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors.
Shiraha H; Gupta K; Drabik K; Wells A
J Biol Chem; 2000 Jun; 275(25):19343-51. PubMed ID: 10764734
[TBL] [Abstract][Full Text] [Related]
18. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.
Rodrigues M; Yates CC; Nuschke A; Griffith L; Wells A
Tissue Eng Part A; 2013 Sep; 19(17-18):1972-83. PubMed ID: 23541003
[TBL] [Abstract][Full Text] [Related]
19. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
20. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
